Disruption and innovation in the biopharmaceutical industry: An interview with GSK’s chief commercial officer Luke Miels episode artwork

EPISODE · Sep 18, 2023 · 22 MIN

Disruption and innovation in the biopharmaceutical industry: An interview with GSK’s chief commercial officer Luke Miels

from The Heidrick & Struggles Leadership Podcast

In this episode of The Heidrick & Struggles Leadership Podcast, Heidrick & Struggles’ Charlie Moore speaks to Luke Miels, the chief commercial officer at GSK, a global biopharmaceutical company headquartered in London. In this interview, Miels discusses the changing healthcare industry, both from an R&D perspective and from a commercial perspective, highlighting the changing digital and AI environment and sharing how the profile of the successful leader is changing as a result. He also discusses some tips for collaboration between R&D and commercial teams, the challenges of change management, and GSK’s culture journey. Finally, he offers advice for leaders and aspiring leaders looking to build a career within a pharmaceutical company. Hosted on Acast. See acast.com/privacy for more information.

Episode metadata supplied by the publisher feed · Published Sep 18, 2023

Embed this episode

Ready to play

Disruption and innovation in the biopharmaceutical industry: An interview with GSK’s chief commercial officer Luke Miels

0:00 22:15

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Heidrick & Struggles Leadership Podcast?

This episode is 22 minutes long.

When was this The Heidrick & Struggles Leadership Podcast episode published?

This episode was published on September 18, 2023.

Can I download this The Heidrick & Struggles Leadership Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!